Similarly, FLT3-ITD mutations are relatively uncommon among MDS patients with a frequency of 0.6–6% [86] and have been associated with higher blasts percentage, increased risk of leukemic transformation and worse overall survival [87]. The gene discussed is FLT3; the disease is myelodysplastic syndrome.